SMYD2 and lung carcinoma: To assess SMYD2 expression in lung cancer, we analyzed the RNA-seq results in normal lung (n = 51) and lung cancer (n = 502) samples derived from The Cancer Genome Atlas (TCGA) portal and found that SMYD2 was overexpressed at the transcriptional level (Fig. 1a).